About
Allegria Therapeutics is a biotechnology company developing therapies that target mast cell dysfunction, focusing on acute and chronic mast-cell-driven allergic and inflammatory diseases.
Explore Allegria Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.